Resverlogix (TSE:RVX) Shares Down 14.3% – Here’s Why

Resverlogix Corp. (TSE:RVX) shares were down 14.3% on Friday . The company traded as low as C$0.09 and last traded at C$0.09. Approximately 185,634 shares were traded during mid-day trading, an increase of 100% from the average daily volume of 93,010 shares. The stock had previously closed at C$0.11.

Resverlogix Trading Down 9.5%

The company has a current ratio of 0.13, a quick ratio of 0.04 and a debt-to-equity ratio of -10.95. The business has a 50 day moving average price of C$0.11 and a 200-day moving average price of C$0.09. The firm has a market capitalization of C$27.30 million, a PE ratio of -3.17 and a beta of 0.93.

Resverlogix (TSE:RVX) last posted its quarterly earnings results on Thursday, November 13th. The biotechnology company reported C$0.00 earnings per share for the quarter. Analysts expect that Resverlogix Corp. will post -0.22 earnings per share for the current year.

About Resverlogix

Resverlogix Corp clinical-stage biotechnology company. The company is developing an advanced epigenetic drug called apabetalone for the treatment of patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, peripheral artery disease, orphan diseases, and neurodegenerative diseases.